Repolarization measures and their relation to sex hormones in postmenopausal women with cardiovascular disease receiving hormone replacement therapy

American Journal of Cardiology

Volumn 90, Issue 10, 2002, Pages 1050-1055

  Nowinski, Karolina ^a   Pripp, Ulla ^a   Carlström, Kjell ^a   Landgren, Britt Marie ^a   Schenck Gustafsson, Karin ^a   Bergfeldt, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PREMARINA; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ELECTROCARDIOGRAM; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEART DEPOLARIZATION; HEART REPOLARIZATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RR INTERVAL; TESTOSTERONE BLOOD LEVEL; TORSADE DES POINTES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; ANDROSTENEDIONE; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART CONDUCTION SYSTEM; HUMAN; MIDDLE AGE; POSTMENOPAUSE; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0037112267     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02768-6     Document Type: Article

References (30)

1. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 270:1993;2590-2597.
2. Kawasaki R., Machado C., Reinoehl J., Fromm B., Baga J.J., Steinman R.T., Lehmann M.H. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol. 6:1995;1032-1038.
3. Lehmann M.H., Hardy S., Archibald D., Quart B., MacNeil D.J. Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation. 94:1996;2535-2541.
4. Pratt C.M., Camm A.J., Cooper W., Friedman P.L., MacNeil D.J., Moulton K.M., Pitt B., Schwartz P.J., Veltri E.P., Waldo A.L. Mortality in the Survival With Oral D-sotalol (SWORD) trial why did patients die? Am J Cardiol. 81:1998;869-876.
5. Rautaharju P.M., Zhou S.H., Wong S., Calhoun H.P., Berenson G.S., Prineas R., Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 8:1992;690-695.
6. Lehmann M.H., Hardy S., Archibald D., MacNeil D.J. JTc prolongation with d, I-sotalol in women versus men. Am J Cardiol. 83:1999;354-359.
7. Bidoggia H., Maciel J.P., Capalozza N., Mosca S., Blaksley E.J., Valverde E., Bertran G., Arini P., Biagetti M.O., Quinteiro R.A. Sex-dependent electrocardiographic pattern of cardiac repolarization. Am Heart J. 140:2000;430-436.
8. Benton R.E., Sale M., Flockhart D.A., Woosley R.L. Greater quinidine-induced QTc interval prolongation in women. Clin Pharmacol Ther. 67:2000;413-418.
9. Hohnloser S.H. Proarrhythmia with class III antiarrhythmic drugs types, risks, and management . Am J Cardiol. 80:1997;82G-89G.
10. Pripp U., Hall G., Csemiczky G., Eksborg S., Landgren B.M., Schenck-Gustafsson K. A randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens. 17:1999;1379-1386.
11. Lepeschkin E., Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 6:1952;378-388.
12. Bergfeldt L., Melander H., Schenck-Gustafsson K. Time-dependent variation in the cardiac conduction system assessed in young healthy individuals at weeks’ interval implications for clinical trials . J Am Coll Cardiol. 18:1991;792-800.
13. Nowinski K., Bergfeldt L. “Normal” response of the QT interval and QT dispersion following intravenous injection of the sodium channel blocker disopyramide methodological aspects . Cardiovasc Drugs Ther. 9:1995;573-580.
14. Lindberg B.S., Lindberg P., Martinsson K., Johansson E.D. Radioimmunological methods for the estimation of oestrone, oestradiol-17beta and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl. 32:1974;5-19.
15. Brody S., Carlström K., Lagrelius A., Lunell N.O., Rosenborg L. Serum levels of 4-androstene-3,17-dione in menstruating and postmenopausal women. Evaluation of a radioimmunoassay and correlation with bone mineral content and endometrial pathology. Acta Obstet Gynecol Scand. 62:1983;531-534.
16. Södergård R., Bäckström T., Shanbhag V., Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 16:1982;801-810.
17. Milne J.R., Hellestrand K.J., Bexton R.S., Burnett P.J., Debbas N.M., Camm A.J. Class 1 antiarrhythmic drugs-characteristic electrocardiographic differences when assessed by atrial and ventricular pacing. Eur Heart J. 5:1984;99-107.
18. Nowinski K., Gadler F., Jensen-Urstad M., Bergfeldt L. Transient pro-arrhythmic state following atrioventricular junctional radiofrequency ablation. Pacing Clin Electrophysiol. 25:2002;291-299.
19. Haseroth K., Seyffart K., Wehling M., Christ M. Effects of progestin-estrogen replacement therapy on QT-dispersion in postmenopausal women. Int J Cardiol. 75:2000;161-165.
20. Longcope C., Baker R., Johnston C.J. Androgen and estrogen metabolism relationship to obesity . Metabolism. 25:1986;235-237.
21. Sbarouni E., Zarvalis E., Kyriakides Z.S., Kremastinos D.T. Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease. Pacing Clin Electrophysiol. 21:1998;2392-2395.
22. Larsen J.A., Tung R.H., Sadananda R., Goldberger J.J., Horvath G., Parker M.A., Kadish A.H. Effects of hormone replacement therapy on QT interval. Am J Cardiol. 82:1998;993-995.
23. Saba S., Link M.S., Homoud M.K., Wang P.J., Estes N.A. III. Effect of low estrogen states in healthy women on dispersion of ventricular repolarization. Am J Cardiol. 87:2001;354-356.
24. Lehmann M.H., Timothy K.W., Frankovich D., Fromm B.S., Keating M., Locati E.H., Taggart R.T., Towbin J.A., Moss A.J., Schwartz P.J., Vincent G.M. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol. 29:1997;93-99.
25. Marsh J.D., Lehmann M.H., Ritchie R.H., Gwathmey J.K., Green G.E., Schiebinger R.J. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 98:1998;256-261.
26. Locati E.H., Zareba W., Moss A.J., Schwartz P.J., Vincent G.M., Lehmann M.H., Towbin J.A., Priori S.G., Napolitano C., Robinson J.L., et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome findings from the International LQTS Registry . Circulation. 97:1998;2237-2244.
27. Bidoggia H., Maciel J.P., Capalozza N., Mosca S., Blaksley E.J., Valverde E., Bertran G., Arini P., Biagetti M.O., Quinteiro R.A. Sex differences on the electrocardiographic pattern of cardiac repolarization possible role of testosterone . Am Heart J. 140:2000;678-683.
28. Pham T.V., Sosunov E.A., Gainullin R.Z., Danilo P. Jr, Rosen M.R. Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by Ik-blocking drugs. Circulation. 103:2001;2207-2212.
29. Rodriguez I., Kilborn M.J., Liu X.K., Pezzullo J.C., Woosley R.L. Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 285:2001;1322-1326.
30. Burger H.G. The endocrinology of the menopause. Maturitas. 23:1996;129-136.